SCTX Stock Chart & Stats
$21.65
--
―
--
Day’s Range― - ―
52-Week Range$21.00 - $25.49
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
$350.34M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding16,182,010
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SCTX FAQ
What was Scribe Therapeutics Inc.’s price range in the past 12 months?
Scribe Therapeutics Inc. lowest stock price was $21.00 and its highest was $25.49 in the past 12 months.
What is Scribe Therapeutics Inc.’s market cap?
Scribe Therapeutics Inc.’s market cap is $350.34M.
When is Scribe Therapeutics Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Scribe Therapeutics Inc.’s earnings last quarter?
Currently, no data Available
Is Scribe Therapeutics Inc. overvalued?
According to Wall Street analysts Scribe Therapeutics Inc.’s price is currently Undervalued.
Does Scribe Therapeutics Inc. pay dividends?
Scribe Therapeutics Inc. does not currently pay dividends.
What is Scribe Therapeutics Inc.’s EPS estimate?
Scribe Therapeutics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scribe Therapeutics Inc. have?
Scribe Therapeutics Inc. has 16,182,010 shares outstanding.
What happened to Scribe Therapeutics Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Scribe Therapeutics Inc.?
Currently, no hedge funds are holding shares in SCTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Scribe Therapeutics Inc.
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.